Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference
27 Febrero 2024 - 7:00AM
Business Wire
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced
that Amit Etkin, M.D., Ph.D., founder and chief executive officer,
will present a company overview at the TD Cowen 44th Annual
Healthcare Conference on Tuesday, March 5, 2024, at 1:30 pm ET.
The presentation will also be available via live webcast on the
Events and Presentations page in the Investors section of Alto’s
website and a replay will be available for 90 days following the
presentation.
About Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company
with a mission to redefine psychiatry by leveraging neurobiology to
develop personalized and highly effective treatment options. Alto’s
Precision Psychiatry Platform™ measures brain biomarkers by
analyzing EEG activity, neurocognitive assessments, wearable data,
and other factors to better identify which patients are more likely
to respond to Alto product candidates. Alto’s clinical-stage
pipeline includes novel drug candidates in depression, PTSD,
schizophrenia, and other mental health conditions. For more
information, visit www.altoneuroscience.com or follow Alto on
X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227427565/en/
Investor Contact: Nick Smith
investors@altoneuroscience.com
Media Contact: Jordann Merkert
media@altoneuroscience.com
Alto Neuroscience (NYSE:ANRO)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Alto Neuroscience (NYSE:ANRO)
Gráfica de Acción Histórica
De May 2023 a May 2024